Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Shares of Novavax Inc. NVAX slid 2.86% to $12.56 Wednesday, on what proved to be an all-around dismal trading session for the ...

Shares of Novavax Inc. NVAX slid 2.05% to $12.93 Tuesday, on what proved to be an all-around mixed trading session for the ...

Moderna's decision to cut R&D by $1.1 billion signals reduced confidence in its Covid business and/or its pipeline. Learn ...

Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know.

Novavax's stock has been surging this year after announcing news of a collaboration with Sanofi. The company recently reported a profit, but whether it can stay out of the red is still a big ...

And since 2022, a sell-off has ensued, with the stock losing more than 91% of its value. Recently, there's been some renewed excitement in Novavax, however, and its shares are up over 150% this year.

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and said the vaccine is ready to ship. Novavax received the green light from ...

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of $23.00. Mayank Mamtani has given his Buy rating due to a ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, we discuss the woman who spearheaded progress in ...

Shares of Novavax were up nearly 9% on Friday likely due to this reason. Year to date, the stock has skyrocketed 157.9% compared with the industry’s 0.6% growth. The deal with Sanofi breathes ...

Shares of Novavax were up nearly 9% on Friday likely due to this reason. Year to date, the stock has skyrocketed 157.9% compared with the industry’s 0.6% growth. Starting next year, Sanofi SNY will ...